Literature DB >> 16024635

Tomographic fluorescence mapping of tumor targets.

Xavier Montet1, Vasilis Ntziachristos, Jan Grimm, Ralph Weissleder.   

Abstract

Methods that allow robust imaging of specific molecular targets and biological processes in vivo should have widespread applications in biology and clinical medicine. Here we use a quantitative, three-dimensional fluorescence-mediated tomographic technique (FMT) that enables rapid measurements of fluorochrome-based affinity tags in live xenograft models. We validate the method by showing its sensitivity in quantitating tumor angiogenesis and therapeutic modulation using an anti-vascular endothelial growth factor antibody. Furthermore, we show the feasibility of simultaneous multichannel measurements of distinct biological phenomena such as receptor tyrosine kinase expression and angiogenesis. FMT measurements can be done serially, with short imaging times and within the same live animal. The described method should be valuable for rapidly profiling biological phenomena in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024635     DOI: 10.1158/0008-5472.CAN-05-0382

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  62 in total

1.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

Review 2.  Optical techniques for the molecular imaging of angiogenesis.

Authors:  Michel Eisenblätter; Carsten Höltke; Thorsten Persigehl; Christoph Bremer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 3.  In vivo imaging in cancer.

Authors:  John Condeelis; Ralph Weissleder
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-22       Impact factor: 10.005

4.  Fluoromodule-based reporter/probes designed for in vivo fluorescence imaging.

Authors:  Ming Zhang; Subhasish K Chakraborty; Padma Sampath; Juan J Rojas; Weizhou Hou; Saumya Saurabh; Steve H Thorne; Marcel P Bruchez; Alan S Waggoner
Journal:  J Clin Invest       Date:  2015-09-08       Impact factor: 14.808

Review 5.  Using in-vivo fluorescence imaging in personalized cancer diagnostics and therapy, an image and treat paradigm.

Authors:  Y Ardeshirpour; V Chernomordik; J Capala; M Hassan; R Zielinsky; G Griffiths; S Achilefu; P Smith; A Gandjbakhche
Journal:  Technol Cancer Res Treat       Date:  2011-12

6.  In vivo imaging of molecularly targeted phage.

Authors:  Kimberly A Kelly; Peter Waterman; Ralph Weissleder
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

7.  Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers.

Authors:  Yun Wu; Weibo Cai; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

8.  Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation.

Authors:  Evan R Trivedi; Allison S Harney; Mary B Olive; Izabela Podgorski; Kamiar Moin; Bonnie F Sloane; Anthony G M Barrett; Thomas J Meade; Brian M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-23       Impact factor: 11.205

9.  Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT).

Authors:  Sylvie Kossodo; Maureen Pickarski; Shu-An Lin; Alexa Gleason; Renee Gaspar; Chiara Buono; Guojie Ho; Agnieszka Blusztajn; Garry Cuneo; Jun Zhang; Jayme Jensen; Richard Hargreaves; Paul Coleman; George Hartman; Milind Rajopadhye; Le Thi Duong; Cyrille Sur; Wael Yared; Jeffrey Peterson; Bohumil Bednar
Journal:  Mol Imaging Biol       Date:  2009-12-04       Impact factor: 3.488

Review 10.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.